{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:32:01Z","timestamp":1793413921578,"version":"4.5.0"},"reference-count":44,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T00:00:00Z","timestamp":1539129600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Br J Dermatol"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1111\/bjd.17149","type":"journal-article","created":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T13:38:52Z","timestamp":1536241132000},"page":"67-75","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Benefit\u2013risk profile of tofacitinib in patients with moderate\u2010to\u2010severe chronic plaque psoriasis: pooled analysis across six clinical trials"],"prefix":"10.1093","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8394-2057","authenticated-orcid":false,"given":"B.E.","family":"Strober","sequence":"first","affiliation":[{"name":"Department of Dermatology University of Connecticut Health Center Farmington CT U.S.A."},{"name":"Probity Medical Research Waterloo ON Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.B.","family":"Gottlieb","sequence":"additional","affiliation":[{"name":"New York Medical College at Metropolitan Hospital New York NY U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.C.M.","family":"Kerkhof","sequence":"additional","affiliation":[{"name":"Radboud University Nijmegen Medical Centre Nijmegen the Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6083-0952","authenticated-orcid":false,"given":"L.","family":"Puig","sequence":"additional","affiliation":[{"name":"Department of Dermatology Hospital de la Santa Creu i Sant Pau Universitat Aut\u00f2noma de Barcelona Medical School Barcelona Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bachelez","sequence":"additional","affiliation":[{"name":"Sorbonne Paris Cit\u00e9 Universit\u00e9 Paris Diderot Assistance Publique\u2010H\u00f4pitaux de Paris Service de Dermatologie, H\u00f4pital Saint\u2010Louis, Paris France"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Chouela","sequence":"additional","affiliation":[{"name":"Universidad de Buenos Aires Buenos Aires Argentina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Imafuku","sequence":"additional","affiliation":[{"name":"Department of Dermatology Faculty of Medicine Fukuoka University Fukuoka Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Tha\u00e7i","sequence":"additional","affiliation":[{"name":"Comprehensive Center for Inflammation Medicine University Hospital Schleswig\u2010Holstein Campus L\u00fcbeck L\u00fcbeck Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Tan","sequence":"additional","affiliation":[{"name":"Pfizer Inc. Groton CT U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Valdez","sequence":"additional","affiliation":[{"name":"Pfizer Inc. Groton CT U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Gupta","sequence":"additional","affiliation":[{"name":"Pfizer Inc. Groton CT U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Kaur","sequence":"additional","affiliation":[{"name":"Pfizer Inc. Collegeville PA U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Frajzyngier","sequence":"additional","affiliation":[{"name":"Pfizer Inc. New York NY U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Wolk","sequence":"additional","affiliation":[{"name":"Pfizer Inc. Groton CT U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,10,10]]},"reference":[{"key":"e_1_2_6_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.12.1537"},{"key":"e_1_2_6_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2008.09.022"},{"key":"e_1_2_6_4_1","doi-asserted-by":"publisher","DOI":"10.2340\/00015555-0770"},{"key":"e_1_2_6_5_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03389.x"},{"key":"e_1_2_6_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.11.055"},{"key":"e_1_2_6_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biologicals.2015.06.004"},{"key":"e_1_2_6_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s13555-014-0056-z"},{"key":"e_1_2_6_9_1","first-page":"30","article-title":"Biologic safety in psoriasis: review of long\u2010term safety data","volume":"8","author":"Mansouri Y","year":"2015","journal-title":"J Clin Aesthet Dermatol"},{"key":"e_1_2_6_10_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2013.5264"},{"key":"e_1_2_6_11_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12745"},{"key":"e_1_2_6_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.12372"},{"key":"e_1_2_6_13_1","doi-asserted-by":"publisher","DOI":"10.7224\/1537-2073.2013-053"},{"key":"e_1_2_6_14_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.13551"},{"key":"e_1_2_6_15_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)62113-9"},{"key":"e_1_2_6_16_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.14018"},{"key":"e_1_2_6_17_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13258"},{"key":"e_1_2_6_18_1","first-page":"252","article-title":"Efficacy of tofacitinib, an oral Janus kinase inhibitor, on clinical signs of moderate\u2010to\u2010severe plaque psoriasis in different body regions","volume":"13","author":"Menter A","year":"2014","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2012.11168.x"},{"key":"e_1_2_6_20_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2016.01.013"},{"key":"e_1_2_6_21_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.0022-202X.2005.23621.x"},{"key":"e_1_2_6_22_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.13702"},{"key":"e_1_2_6_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3999(01)00296-3"},{"key":"e_1_2_6_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2230.1994.tb01167.x"},{"key":"e_1_2_6_25_1","first-page":"1039","article-title":"Effectiveness of systemic treatment agents on psoriatic nails: a comparative study","volume":"12","author":"Demirsoy EO","year":"2013","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_26_1","first-page":"939","article-title":"Treatment of nail psoriasis with TNF\u2010\u03b1 or IL12\/23 inhibitors","volume":"11","author":"Jemec GB","year":"2012","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_27_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.732"},{"key":"e_1_2_6_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15707"},{"key":"e_1_2_6_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2011.04065.x"},{"key":"e_1_2_6_30_1","doi-asserted-by":"publisher","DOI":"10.2165\/11310770-000000000-00000"},{"key":"e_1_2_6_31_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2016-210457"},{"key":"e_1_2_6_32_1","doi-asserted-by":"crossref","unstructured":"WollenhauptJ SilverfieldJ LeeEBet al.Tofacitinib an oral Janus kinase inhibitor in the treatment of rheumatoid arthritis: safety and efficacy in open\u2010label long\u2010term extension studies over 9 years. Presented at the American College of Rheumatology\/Association of Rheumatology Health Professionals Annual Scientific Meeting San Diego CA U.S.A. 3\u20138 November 2017; Abstr. 522","DOI":"10.1136\/annrheumdis-2017-eular.1166"},{"key":"e_1_2_6_33_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1606910"},{"key":"e_1_2_6_34_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615975"},{"key":"e_1_2_6_35_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1615977"},{"key":"e_1_2_6_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.13409"},{"key":"e_1_2_6_37_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kep176"},{"key":"e_1_2_6_38_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2000.00058.x"},{"key":"e_1_2_6_39_1","unstructured":"National Institutes of Health.LiverTox. Clinical and research information on drug\u2010induced liver injury. Available at:https:\/\/livertox.nih.gov(last accessed 28 September 2018)."},{"key":"e_1_2_6_40_1","first-page":"1","article-title":"Clinical management of psoriasis: principles and practice","volume":"67","author":"Lebwohl M","year":"2001","journal-title":"Cutis"},{"key":"e_1_2_6_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pec.2006.08.004"},{"key":"e_1_2_6_42_1","first-page":"84","article-title":"Patient preferences regarding rheumatoid arthritis therapies: a conjoint analysis","volume":"9","author":"Louder AM","year":"2016","journal-title":"Am Health Drug Benefits"},{"key":"e_1_2_6_43_1","first-page":"311","article-title":"Anti\u2010IL\u201017 agents for psoriasis: a review of phase III data","volume":"15","author":"Farahnik B","year":"2016","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_6_44_1","doi-asserted-by":"publisher","DOI":"10.3109\/09546634.2015.1027167"},{"key":"e_1_2_6_45_1","doi-asserted-by":"publisher","DOI":"10.7326\/M15-0288"}],"container-title":["British Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbjd.17149","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.17149","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/bjd.17149","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bjd.17149","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,14]],"date-time":"2023-02-14T13:43:35Z","timestamp":1676382215000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/bjd\/article\/180\/1\/67\/6601612"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,10]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,1,2]]},"published-print":{"date-parts":[[2019,1]]}},"alternative-id":["10.1111\/bjd.17149"],"URL":"https:\/\/doi.org\/10.1111\/bjd.17149","archive":["Portico"],"relation":{},"ISSN":["0007-0963","1365-2133"],"issn-type":[{"value":"0007-0963","type":"print"},{"value":"1365-2133","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,10]]}}}